Science and Research committee  The answer to that really stems from what we've learned in the course of the pandemic about the need to ensure we have the infrastructure in Canada to be able to fully synthesize and be self-sufficient with respect to vaccine production, and, in reality, a number of other agents

Science and Research committee  It actually is a broader combination of issues than what you've delineated. In the early days of the pandemic it was important to really quickly be able to scale up and get vaccines into the arms of Canadians, and that capacity did not reside within Canada to do that, hence the

Science and Research committee  The core of the question is, in fact, a very good one. As we've begun to look more carefully at bringing forward EDI—equity, diversity and inclusiveness—anti-racism principles into all of our granting processes, we are very much aware that there are regional differences, urban ve

Science and Research committee  Yes, indeed, we are very close with Rémi Quirion, a colleague who chairs the FRQ, the funding agency that's in place. We have had a number of conversations over the course of the last several years with regard to the successes he has seen by bringing those entities together under

Science and Research committee  The valley of death is actually populated by a number of different issues that need to be addressed. The first is to ensure that the funding is in place to ensure that the development of the research ideas are there to begin with. Also, there is a need to ensure that there is a

Science and Research committee  Again, I will return to the biomanufacturing strategy and life sciences strategy that's embedded with that because it's a good example of knitting together across multiple different departments and agencies the capacity to actually see something carried all the way through, and t

Science and Research committee  Yes, in fact, CIHR does conduct research, and one of its pillars specifically supports health outcomes and investments, to look at how the health care system has improved, not just during the period of the pandemic but also prior to that. It's a matter of looking at the best ways

Science and Research committee  Madam Chair, I thank the member for that question. It's a crucial one at this moment in time. It actually speaks to the biomanufacturing and life sciences initiative that's being built coming out of the pandemic to strengthen our ability to create that pipeline and then sustain

Science and Research committee  Thank you. Moving this vision forward will require a vibrant, globally competitive research community. It will require us to continue to work hand in hand with our partners. With our tri-agency colleagues, we will continue to enhance collaboration and harmonization. We will work

Science and Research committee  Sorry.

Science and Research committee  [Technical difficulty—Editor]

Science and Research committee  Thank you, Madam Chair. I wish to thank the committee for the invitation to appear here today. It is a great privilege, both as CIHR's president and as a scientist, to join my colleagues in addressing the inaugural members of Canada's parliamentary committee dedicated to scienc

Health committee  Looking forward to the next steps of research that will be needed to be done, it will build on these investments to which the minister was referring. In particular, looking at the long COVID consequences, both in terms of the type of biology that underlies this syndrome, which we

Health committee  Thank you very much, Chair, Minister and honourable member, for the question. In fact, one of the major investments that this supplementary discussion is about is a clinical trials fund, which will in fact begin to develop again the clinical trials expertise in this country and

Health committee  Mr. Chair, might I be allowed to answer that question?